| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
S |
$24.18 |
$20,167 |
D/D |
(834) |
31,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-04-01 |
4 |
S |
$25.45 |
$63,626 |
D/D |
(2,500) |
31,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-04-20 |
4 |
S |
$27.00 |
$355,455 |
D/D |
(13,165) |
22,835 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-06-03 |
4 |
S |
$24.25 |
$72,746 |
D/D |
(3,000) |
10,416 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2013-04-30 |
4 |
S |
$63.29 |
$1,265,800 |
D/D |
(20,000) |
44,589 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-01 |
4 |
S |
$59.67 |
$42,666 |
D/D |
(715) |
73,850 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-09 |
4 |
S |
$57.91 |
$201,474 |
D/D |
(3,479) |
67,850 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-13 |
4 |
S |
$58.23 |
$83,498 |
D/D |
(1,434) |
64,850 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-13 |
4/A |
S |
$58.23 |
$83,498 |
D/D |
(1,434) |
63,415 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-05-16 |
4 |
S |
$56.86 |
$105,994 |
D/D |
(1,864) |
60,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2014-11-10 |
4 |
S |
$86.55 |
$1,730,982 |
D/D |
(20,000) |
76,550 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2015-05-01 |
4 |
S |
$114.59 |
$47,442 |
D/D |
(414) |
89,646 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2016-05-26 |
4 |
S |
$87.34 |
$1,317,100 |
D/D |
(15,000) |
115,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-08-24 |
4 |
S |
$99.00 |
$1,237,500 |
D/D |
(12,500) |
142,667 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-08-27 |
4 |
S |
$100.00 |
$1,250,000 |
D/D |
(12,500) |
130,167 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-22 |
4 |
S |
$81.70 |
$2,168,403 |
D/D |
(26,479) |
6,332 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-25 |
4 |
S |
$78.88 |
$278,226 |
D/D |
(3,521) |
6,332 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2023-08-10 |
4 |
S |
$90.43 |
$1,085,111 |
D/D |
(12,000) |
176,187 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2024-03-05 |
4 |
S |
$85.18 |
$3,010,396 |
D/D |
(35,341) |
212,117 |
0 |
- |
|
294 Records found
|
|
Page 12 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
